Operating Lease, Right-of-Use Asset of Propanc Biopharma, Inc. from 30 Sep 2019 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Propanc Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2019 to 31 Dec 2025.
Propanc Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $50,901.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$50,901			31 Dec 2025	10-Q	17 Feb 2026	2026	Q2
Q3 2025	$56,279			30 Sep 2025	10-Q	14 Nov 2025	2026	Q1
Q2 2025	$59,413	+$41,614	+234%	30 Jun 2025	10-Q	17 Feb 2026	2026	Q2
Q1 2025	$62,126			04 May 2025	10-Q	17 Feb 2026	2026	Q2
Q2 2024	$17,799			30 Jun 2024	10-K	29 Sep 2025	2025	FY
Q1 2023	$44,524			31 Mar 2023	10-Q	15 May 2023	2023	Q3
Q4 2022	$50,671			31 Dec 2022	10-Q	10 Feb 2023	2023	Q2
Q3 2022	$53,025			30 Sep 2022	10-Q	14 Nov 2022	2023	Q1
Q2 2022	$62,523			30 Jun 2022	10-Q	15 May 2023	2023	Q3
Q1 2021	$2,397	-$22,562	-90%	31 Mar 2021	10-Q	14 May 2021	2021	Q3
Q4 2020	$9,699	-$25,692	-73%	31 Dec 2020	10-Q	12 Feb 2021	2021	Q2
Q3 2020	$15,792	-$24,537	-61%	30 Sep 2020	10-Q	16 Nov 2020	2021	Q1
Q2 2020	$21,682			30 Jun 2020	10-K	28 Sep 2021	2021	FY
Q1 2020	$24,959			31 Mar 2020	10-Q	15 May 2020	2020	Q3
Q4 2019	$35,391			31 Dec 2019	10-Q	14 Feb 2020	2020	Q2
Q3 2019	$40,329			30 Sep 2019	10-Q	14 Nov 2019	2020	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.